Robert L. Chevalier

10.0k total citations · 2 hit papers
204 papers, 7.4k citations indexed

About

Robert L. Chevalier is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert L. Chevalier has authored 204 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Pediatrics, Perinatology and Child Health, 70 papers in Molecular Biology and 63 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert L. Chevalier's work include Birth, Development, and Health (63 papers), Pediatric Urology and Nephrology Studies (61 papers) and Renal and related cancers (53 papers). Robert L. Chevalier is often cited by papers focused on Birth, Development, and Health (63 papers), Pediatric Urology and Nephrology Studies (61 papers) and Renal and related cancers (53 papers). Robert L. Chevalier collaborates with scholars based in United States, South Korea and France. Robert L. Chevalier's co-authors include Barbara A. Thornhill, Michael S. Forbes, R. Ariel Gómez, Robert M. Carey, M J Peach, Jennifer T. Wolstenholme, Susan C. Kiley, Kevin R. Lynch, Allen D. Everett and Alice Y. Chang and has published in prestigious journals such as Journal of Clinical Investigation, Physiological Reviews and PEDIATRICS.

In The Last Decade

Robert L. Chevalier

199 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy

2009 825 citations Robert L. Chevalier, Michael S. Forbes et al. Kidney International profile →
The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction

2016 322 citations Robert L. Chevalier American Journal of Physiology-Renal Physiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert L. Chevalier United States	48	2.9k	2.6k	2.0k	1.9k	1.1k	204	7.4k
Saulo Klahr United States	58	3.7k 1.3×	1.9k 0.7×	5.4k 2.7×	2.6k 1.3×	2.0k 1.7×	183	12.6k
Iekuni Ichikawa United States	69	4.6k 1.6×	1.9k 0.7×	4.7k 2.3×	2.2k 1.1×	5.2k 4.6×	216	13.9k
Michel Baum United States	37	2.2k 0.8×	1.1k 0.4×	2.2k 1.1×	964 0.5×	262 0.2×	135	5.2k
E. Darracott Vaughan United States	45	1.6k 0.6×	579 0.2×	612 0.3×	3.3k 1.7×	1.1k 0.9×	158	8.3k
B M Brenner United States	36	1.5k 0.5×	1.3k 0.5×	1.7k 0.8×	1.1k 0.6×	1.8k 1.6×	67	5.6k
John P. Hayslett United States	46	2.1k 0.7×	834 0.3×	1.8k 0.9×	1.6k 0.8×	344 0.3×	154	5.8k
York Pei Canada	54	4.7k 1.6×	1.1k 0.4×	2.8k 1.4×	1.2k 0.6×	1.1k 0.9×	147	10.0k
Hirokazu Okada Japan	36	3.4k 1.2×	348 0.1×	2.8k 1.4×	1.7k 0.9×	1.2k 1.0×	220	8.9k
Dieter Haffner Germany	44	1.5k 0.5×	1.2k 0.5×	3.2k 1.6×	996 0.5×	365 0.3×	247	6.5k
Leon G. Fine United States	46	2.7k 1.0×	505 0.2×	1.8k 0.9×	1.1k 0.6×	466 0.4×	125	5.8k

Countries citing papers authored by Robert L. Chevalier

Since Specialization

Citations

This map shows the geographic impact of Robert L. Chevalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Chevalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Chevalier more than expected).

Fields of papers citing papers by Robert L. Chevalier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Chevalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Chevalier. The network helps show where Robert L. Chevalier may publish in the future.

Co-authorship network of co-authors of Robert L. Chevalier

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Chevalier. A scholar is included among the top collaborators of Robert L. Chevalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Chevalier. Robert L. Chevalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chevalier, Robert L.. (2023). Bioenergetics: the evolutionary basis of progressive kidney disease. Physiological Reviews. 103(4). 2451–2506. 7 indexed citations

2.

Chevalier, Robert L.. (2023). Evolution-informed therapy for kidney disease. Evolution Medicine and Public Health. 11(1). 316–317. 1 indexed citations

3.

Chevalier, Robert L.. (2023). Why is chronic kidney disease progressive? Evolutionary adaptations and maladaptations. American Journal of Physiology-Renal Physiology. 325(5). F595–F617. 3 indexed citations

4.

Chevalier, Robert L.. (2023). CAKUT: A Pediatric and Evolutionary Perspective on the Leading Cause of CKD in Childhood. Pediatric Reports. 15(1). 143–153. 16 indexed citations

5.

Luyckx, Valérie A. & Robert L. Chevalier. (2021). Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade‐offs. Experimental Physiology. 107(5). 410–414. 16 indexed citations

6.

Chevalier, Robert L.. (2012). Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin. Current Medicinal Chemistry. 19(27). 4572–4580. 16 indexed citations

7.

Chevalier, Robert L., Michael S. Forbes, & Barbara A. Thornhill. (2011). Formation of atubular glomeruli in the developing kidney following chronic urinary tract obstruction. Pediatric Nephrology. 26(9). 1381–1385. 10 indexed citations

8.

Chevalier, Robert L., Barbara A. Thornhill, Michael S. Forbes, & Susan C. Kiley. (2009). Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatric Nephrology. 25(4). 687–697. 156 indexed citations

9.

Chevalier, Robert L., Michael S. Forbes, & Barbara A. Thornhill. (2009). Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney International. 75(11). 1145–1152. 825 indexed citations breakdown →

10.

Forbes, Michael S., et al.. (2006). Renal vascular endothelial growth factor in neonatal obstructive nephropathy. II. Exogenous VEGF. American Journal of Physiology-Renal Physiology. 292(1). F168–F174. 7 indexed citations

11.

Chevalier, Robert L.. (2000). The Cell Biology of Obstructive Nephropathy. 2000. 88–88.

12.

Chevalier, Robert L., Barbara A. Thornhill, & Alice Y. Chang. (2000). Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney International. 58(5). 1987–1995. 10 indexed citations

13.

Chevalier, Robert L., Barbara A. Thornhill, & Alice Y. Chang. (2000). Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney International. 58(5). 1987–1995. 89 indexed citations

14.

McCarty, Richard, David A. Blizard, & Robert L. Chevalier. (1999). Development of the hypertensive phenotype: basic and clinical studies. Elsevier eBooks. 19 indexed citations

15.

Chevalier, Robert L., Sharad Goyal, Jennifer T. Wolstenholme, & Barbara A. Thornhill. (1998). Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor. Kidney International. 54(1). 38–47. 96 indexed citations

16.

José, Pedro A., Robert D. Fildes, R. Ariel Gómez, Robert L. Chevalier, & J Robillard. (1994). Neonatal renal function and physiology. Current Opinion in Pediatrics. 6(2). 172–177. 27 indexed citations

17.

Chevalier, Robert L., R. Ariel Gómez, Robert M. Carey, et al.. (1988). Renal Effects of Atrial Natriuretic Peptide Infusion in Young and Adult Rats. Pediatric Research. 24(3). 333–337. 26 indexed citations

18.

Chevalier, Robert L., R. Ariel Gómez, & Catherine E. Jones. (1988). Developmental determinants of recovery after relief of partial ureteral obstruction. Kidney International. 33(4). 775–781. 53 indexed citations

19.

Chevalier, Robert L.. (1984). Polydipsia and enuresis in childhood renin-dependent hypertension. The Journal of Pediatrics. 104(4). 591–593. 5 indexed citations

20.

Chevalier, Robert L. & Alan D. Rogol. (1982). Tolmetin sodium in the management of nephrogenic diabetes insipidus. The Journal of Pediatrics. 101(5). 787–789. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact